Table 1

Demographics and neonatal course according to RSV status

	RSV proven (n = 45)	Probable bronchiolitis (n = 24)	Other respiratory (n = 60)	Non-respiratory (n = 106)
Gestational age (weeks)	26 (24–31)	26 (23–31)	27 (22–31)	27 (24–31)
Birth weight (g)	863 (640–2178)	834 (590–1538)	972 (630–1696)	960 (510–3000)
Antenatal steroids	81	93	88	86
Postnatal surfactant	91	88	90	84
CPAP	54	46	51	64
IPPV	98	100	98	95
HFOV	5	14	10	1
NO	2	4	5	3
Airleak	11	29	20	11
PDA	38	46	40	31
Postnatal dexamethasone	41	50	38	36
Duration of IPPV (days)	12 (0–58)^1-150	4.5 (0–62)	10 (0–103)^1-150	7 (0–96)
Duration of admission (days)	91 (16–360)^1-160	83 (18–260)	76 (10–464)^1-160	66 (2–827)
Home oxygen	42	25	52	30

Data are presented as median (range) or (%).
↵1-150 p < 0.05,
↵1-160 p < 0.01.
CPAP, continuous positive airway pressure; IPPV, intermittent positive pressure ventilation; HFOV, high frequency oscillatory ventilation; NO, nitric oxide; PDA, patent ductus arteriosus.